Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors

It has been indicated that proton pump inhibitor (PPI) use is associated with a loss of the anti-fracture efficacy of alendronate (AD). However, there are few prospective studies that have investigated the efficacy of AD on lumbar bone mineral density (BMD) in osteoporotic patients who are using PPI...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biomed Rep
Main Authors: Asaoka, Daisuke, Nagahara, Akihito, Hojo, Mariko, Matsumoto, Kenshi, Ueyama, Hiroya, Matsumoto, Kohei, Izumi, Kentaro, Takeda, Tsutomu, Komori, Hiroyuki, Akazawa, Yoichi, Shimada, Yuji, Osada, Taro, Watanabe, Sumio
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2016
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950806/
https://ncbi.nlm.nih.gov/pubmed/27446535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.710
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki